李洪涛;李俊;

• 1:宿迁市第一人民医院

摘要(Abstract)：

目的研究血清中25-羟基维生素D[25-hydroxyvitamin D,25(OH)D]水平与脑出血的相关性。方法收集111例脑出血患者和正常对照组130例,比较脑出血组和健康对照组血清25-羟基维生素D水平差异。结果脑出血常见危险因素如收缩压(SBP)、舒张压(DBP)、血糖、TG、高血压史、吸烟史、饮酒史,脑出血组明显高于对照组(P<0.05);脑出血组血清25-羟基维生素D水平(44.81±20.55 nmol/L对51.39±20.36 nmol/L,F=0.008,P=0.013)明显低于对照组,2组比较差异有统计学意义。采用二分类Logistic回归分析25-羟基维生素D与脑出血的相关性(β=0.706,OR=2.026,95%CI(0.984～4.175))。结论血清25-羟基维生素D与脑出血有一定的相关性,在脑出血的发生过程中扮演了重要的角色,可能是除高血压、糖尿病、高血脂和饮酒等之外脑出血的另一个独立危险因素。

关键词(KeyWords)： 脑出血;维生素D;高血压;糖尿病;预后

Abstract:

Keywords:

基金项目(Foundation): 宿迁市科技计划资助项目(编号:S201905)

作者(Author): 李洪涛;李俊;

Email:

DOI:

参考文献(References)：

• [1] 冯微,张炜,李建玲,等.25-羟维生素D3 Hcy LDL与无症状性脑梗死患者颈动脉斑块的关系分析[J].中国实用神经疾病杂志,2020,23(18):1584-1589.DOI:10.12083/SYSJ.2020.18.021.
• [2] PRABHAKAR P,MA JUMDAR V,KULKARNI G B,et al.Genetic variants of vitamin D receptor and susceptibility to ischemic stroke[J].Biochem Biophys Res Commun,2015,456(2):631-636.DOI:10.1016/j.bbrc.2014.12.007.
• [3] RY O,MOMOSAK I,MASAHIR O,et al.Vitamin D Supplementation andPost-Stroke Rehabilitation:A Randomized,Double-Blind,Placebo-Controlled Trial[J].Nutrients,2019,11(6).DOI:10.3390/nu11061295.
• [4] VAN BALLEGOOIJEN A J,GANSEVOORT R T,LAMBERS-HEERSPINK H J,et al.Plasma 1,25-Dihydroxyvitamin D and the Risk of Developing Hypertension:The Prevention of Renal and Vascular End-Stage Disease Study[J].Hypertension,2015,66(3):563-570.DOI:10.1161/HYPERTENSIONAHA.115.05837.
• [5] SHI H,CHEN H,ZHANG Y,et al.25-Hydroxyvitamin D level,vitamin D intake,and risk of stroke:A dose-response meta-analysis[J].Clin Nutr,2019,39(7):2025-2034.DOI:10.1016/j.clnu.2019.08.029.
• [6] BATEMAN R M,SHARPE M D,JAGGER J E,et al.36th International Symposium on Intensive Care and Emergency Medicine:Brussels,Belgium.15-18 March 2016[J].Crit Care,2016,20(Suppl 2):94.DOI:10.1186/s13054-016-1208-6.
• [7] Al-SHAHWAN M A,Al-OTHMAN A M,Al-DAGHRI N M,et al.Effects of 12-month,2000IU/day vitamin D supplementation on treatment na?ve and vitamin D deficient Saudi type 2 diabetic patients[J].Saudi Med J,2015,36(12):1432-1438.DOI:10.15537/smj.2015.12.12923.
• [8] KIM H A,PERRELLI A,RAGNI A,et al.Vitamin D Deficiency and the Risk of Cerebrovascular Disease[J].Antioxidants(Basel),2020,9(4):327.DOI:10.3390/antiox9040327.
• [9] HOLCK M F,BINKLEY N C,BISCHOFF-FERRARI H A,et al.Evaluation,treatment and prevention of vitamin D deficiency:an Endocrine Society Clinical Practice Guideline[J].J Clin Endocrinol Metab,2011,96:1911-1930.DOI:10.1210/jc.2011-0385.
• [10] ROSS A C,MANSON J E,ABRAMS S A,et al.The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine:what clinicians need to know[J].Clin Endocrinol Metab,2011,96(1):53-58.DOI:10.1017/S136898001100 0565.
• [11] NUDY M,KRAKOWKSI G,GHAHRAMANI M,et al.Vitamin D supplementation,cardiac events and stroke:A systematic review and meta-regression analysis[J].Int J Cardiol Heart Vasc,2020,28:100537.DOI:10.1016/j.ijcha.2020.100537.
• [12] YOU X,ZHOU Y,ZHANG J,et al.Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis[J].BMC Nephrol,2020,21(1):183.DOI:10.21203/rs.2.21446/v4.
• [13] WOOD J R,CONNOR C G,CHENG P,et al.Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium(PDC) is not worse than in youth without diabetes[J].Pediatr Diabetes,2015,17(8):584-591.DOI:10.1111/pedi.12340.
• [14] SCRAGG R.Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study:A Randomized Clinical Trial[J].JAMA Cardiol,2017,2(6):608-616.DOI:10.1001/jamacardio.2017.0175.
• [15] MANSON J E,COOK N R,LEE I M,et al.Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease[J].N Engl J Med,2019,380(1):33-44.DOI:10.1056/NEJMoa1809944.
• [16] JENKINS D J,SPENCE J D,GIOVANNUCCI E L,et al.Supplemental vitamins and minerals for CVD prevention and treatment[J].JACC,2018,71(21):2570-2584.DOI:10.1016/j.jacc.2018.04.020.
• [17] ZHANG R,LI B,GAO X,et al.Serum 25-hydroxyvitamin D and the risk of cardiovascular disease:dose-response meta-analysis of prospective studies[J].Am J Clin Nutr,2017,105:810-819.DOI:10.3945/ajcn.116.140392.
• [18] CROWE F L,THAVAKARAN R,GITTOES N,et al.Non-linear associations of 25-hydroxyvitamin D concentrations with risk of cardiovascular disease and all-cause mortality:results from the Health Improvement Network (THIN) database[J].J Steroid Biochem MolBiol,2019,195,Article105480.DOI:105480.10.1016/j.jsbmb.2019.105480.
• [19] LIBERATI A,ALTMAN D G,TETZLAFF J,et al.The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions:explanation and elaboration[J].Ann Intern Med,2009,151(4):W65-W94.DOI:10.1136/bmj.b2700.
• [20] MARTINEAU A R,HANIFA Y,WITT K D,et al.Double-blind randomised controlled trial of vitamin D3 supplementation for the prevention of acute respiratory infection in older adults and their carers (ViDiFlu)[J].Thorax,2015,70(10):953-960.DOI:10.1136/thoraxjnl-2015-206996.
• [21] ALFIERI D F,LEHMANN M F,OLIVEIRA S R,et al.Vitamin D deficiency is associated with acute ischemic stroke,C-reactive protein,and short-term outcome[J].Metab Brain Dis,2017,32:493-502.DOI:10.1007/s11011-016-9939-2.
• [22] BURGOS R,BRETóN I,CEREDA E,et al.ESPEN guideline clinical nutrition in neurology[J].Clin.Nutr,2018,37:354-396.DOI:10.1016/j.clnu.2017.09.003.
• [23] GUPTA A,PRABHAKAR S,MODI M,et al.Effect of Vitamin D and calcium supplementation on ischaemic stroke outcome:A randomised controlled open-label trial[J].Int J Clin Pract,2016,70:764-770.DOI:10.1111/ijcp.12866.
• [24] 王栋,白雪蕾,吴环立.急性期脑出血患者血清MMP-2 ICAM-1与IL-6 TNF-α水平和脑水肿的关系[J].中国实用神经疾病杂志,2020,22(12):1336-1341.DOI:
• [25] CLVO-ROMERO J M,RAMIRO-LOZANO J M.Metabolic effects of supplementation with vitamin D in type 2 diabetic patients with vitamin D deficiency[J].Diabetes Metab Syndr,2015,S1871-4021(15)30034-30035.DOI:10.1016/j.dsx.2015.09.008.
• [26] DE BOER I H,TINKER L F,CONNELLY S,et al.Calcium plus vitamin Dsupplementation and the risk of incident diabetes in the Women' s Health Initiative[J].Diabetes Care,2008,31(4):701-707.DOI:10.2337/dc07-1829.
• [27] BR?NDUM-JACOBSEN P,NORDESTGAARD B G,SCHNOHR P,et al.25-hydroxyvitamin D and symptomatic ischemic stroke:an original study and meta-analysis[J].Ann Neurol,2013,73(1):38-47.DOI:10.1002/ana.23738.
• [28] KOJIMA G,BELL C,ABBOTT R D,et al.Low dietary vitamin D predicts 34 year incident stroke.The Honolulu Heart Program[J].Stroke,2012,43(8):2163-2167.DOI:10.1161/STROKEAHA.112.651752.
• [29] DAUBAIL B,JACQUIN A,GUILLAND J C,et al.Association between Serum Concentration of Vitamin D and 1-Year Mortality in Stroke Patients[J].Cerebrovasc Dis,2014,37:364-367.DOI:10.1159/000362534.
• [30] BARBARAWI M,KHEIRI B,ZAYED Y,et al.Vitamin D supplementation and cardiovascular disease risks in more than 83,000 individuals in 21 randomized clinical trials:a meta-analysis[J].JAMA Cardiology,2019,4(8):765-775.DOI:10.1001/jamacardio.2019.1870.
• [31] KIM J M,LEE S H,CHO S H,et al.Cerebellar infarction presenting with isolated positional vertigo:differentiating factors for benign paroxysmal positional vertigo[J].Neurol Sci,2020 Jul 28.DOI:10.1007/s10072-020-04617-w.
• [32] ATIF F,YOUSUF S,ESPINOSA-GARCIA C,et al.Post-ischemic stroke systemic inflammation:Immunomodulation by progesterone and vitamin D hormone[J].Neuropharmacology,2020,181:108327.DOI:10.1016/j.neuropharm.2020.108327.
• [33] KIM C,LEE S H,LIM J S,et al.Impact of 25-Hydroxyvitamin D on the Prognosis of Acute Ischemic Stroke:Machine Learning Approach[J].Front Neurol,2020,11:37.DOI:10.3389/fneur.2020.00037.
• [34] LI Y R,LI H.Protective effects of exogenous vitamin D on nerve injury in mice with cerebral ischemia/reperfusion.Zhongguo Ying Yong Sheng Li Xue Za Zhi,2019,35(4):300-303.DOI:10.12047/j.cjap.5794.2019.063.
• [35] GUO X,YUAN J,WANG J,et al.Calcitriol alleviates global cerebral ischemia-induced cognitive impairment by reducing apoptosis regulated by VDR/ERK signaling pathway in rat hippocampus[J].Brain Res,2019,1724:146430.DOI:10.1016/j.brainres.2019.146430.
• [36] BAO G Q,YU J Y.Vitamin D3 promotes cerebral angiogenesis after cerebral infarction in rats by activating Shh signaling pathway[J].Eur Rev Med Pharmacol Sci,2018,22(20):7069-7077.DOI:10.26355/eurrev_201810_16179.